Sequenom to Net $18M in Private Stock Placement; Shares Surge 14 Percent | GenomeWeb
NEW YORK (GenomeWeb News) — Sequenom will sell $20 million worth of its common stock to new and existing institutional investors, the company said today.
 
The company said it plans to sell 6.7 million shares for $3 apiece, a 1-cent premium over yesterday’s closing price of $2.99. Sequenom said it plans to close the sale by Friday.  
 
After deductions for expenses, Sequenom said it expects the sale to net around $18.4 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.